Vaccination Against RhoC in Prostate Cancer Patients Induces Potent and Long-Lasting CD4+ T Cell Responses with Cytolytic Potential in the Absence of Clinical Efficacy: A Randomized Phase II Trial

Salo, Sara Fresnillo; Schuhmacher, Juliane; Rahbech, Anne; Pedersen, Sara Ram; Seremet, Tina; Matillas, Valero Andreu; Schoellhorn, Anna; Roder, Andreas; Jorgensen, Steffen Wad; Brasso, Klaus; Gouttefangeas, Cecile; Straten, Per thor

dc.contributor.author	Schuhmacher, Juliane
dc.contributor.author	Matillas, Valero Andreu
dc.contributor.author	Schöllhorn, Anna
dc.contributor.author	Gouttefangeas, Cécile
dc.date.accessioned	2026-03-09T08:18:27Z
dc.date.available	2026-03-09T08:18:27Z
dc.date.issued	2025
dc.identifier.issn	2076-393X
dc.identifier.uri	http://hdl.handle.net/10900/176410
dc.language.iso	en	de_DE
dc.publisher	Basel : Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/vaccines13040390	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Vaccination Against RhoC in Prostate Cancer Patients Induces Potent and Long-Lasting CD4+ T Cell Responses with Cytolytic Potential in the Absence of Clinical Efficacy: A Randomized Phase II Trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_00992
utue.personen.roh	Salo, Sara Fresnillo
utue.personen.roh	Schuhmacher, Juliane
utue.personen.roh	Rahbech, Anne
utue.personen.roh	Pedersen, Sara Ram
utue.personen.roh	Seremet, Tina
utue.personen.roh	Matillas, Valero Andreu
utue.personen.roh	Schoellhorn, Anna
utue.personen.roh	Roder, Andreas
utue.personen.roh	Jorgensen, Steffen Wad
utue.personen.roh	Brasso, Klaus
utue.personen.roh	Gouttefangeas, Cecile
utue.personen.roh	Straten, Per thor
dcterms.isPartOf.ZSTitelID	Vaccines	de_DE
dcterms.isPartOf.ZS-Issue	Article 390	de_DE
dcterms.isPartOf.ZS-Volume	13 (4)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE